Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis

about

Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis

Item

http://www.wikidata.org/entity/Q37206473

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis

@en

Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis.

@nl

type

Item

label

Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis

@en

Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis.

@nl

prefLabel

Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis

@en

Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis.

@nl

P1476

Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis

@en

P2093

Adolf Stiehl

http://www.w3.org/2001/XMLSchema#string

Annika Gauss

http://www.w3.org/2001/XMLSchema#string

Christian Rupp

http://www.w3.org/2001/XMLSchema#string

Daniel Gotthardt

http://www.w3.org/2001/XMLSchema#string

Johannes Krisam

http://www.w3.org/2001/XMLSchema#string

Peter Sauer

http://www.w3.org/2001/XMLSchema#string

Petra Kloeters-Plachky

http://www.w3.org/2001/XMLSchema#string

Yvonne Leopold

http://www.w3.org/2001/XMLSchema#string

P2860

Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion

A model to predict survival in patients with end-stage liver disease

Endoscopic retrograde cholangiopancreatography in diagnosis and treatment of primary sclerosing cholangitis.

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.

Primary sclerosing cholangitis: diagnostic and therapeutic problems.

S100A9 is a biliary protein marker of disease activity in primary sclerosing cholangitis.

Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis.

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

Urinary calprotectin and posttransplant renal allograft injury.

Advances and controversies in the pathogenesis and management of primary sclerosing cholangitis.

P304

e3510

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000003510

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

W Stremmel

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27124059

http://www.w3.org/2001/XMLSchema#string

P921

cholangitis

biomarker

P932

4998722

http://www.w3.org/2001/XMLSchema#string